Shanghai Shen Lian Biomedical Corporation
688098.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.42B
Close$
$-3.04
136.5% downside
Current Fair Value
136.5% downsideOvervalued by 136.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.42 Billion |
|---|---|
| Enterprise Value | $3.41 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.05 |
| Beta | 0.54 |
| Outstanding Shares | 380,665,617 |
Return
| Return on Equity | -1.83% |
|---|---|
| Return on Assets | -1.64% |
| Return on Invested Capital | -1.64% |
Valuation & Multiples
| P/E Ratio | -127.8 |
|---|---|
| PEG | -166.39 |
| Price to Sales | - |
| Price to Book Ratio | 2.77 |
| Enterprise Value to Revenue | 12.23 |
| Enterprise Value to EBIT | -147.6 |
| Enterprise Value to Net Income | -135 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Shen Lian Biomedical Corporation
375 employees
CEO: Dongsheng Nie Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary...